Tlcd1tm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Tlcd1tm1(KOMP)Wtsi |
Name: |
TLC domain containing 1; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4419235 |
Gene: |
Tlcd1 Location: Chr11:78068956-78071646 bp, + strand Genetic Position: Chr11, 46.74 cM, cytoband B5
|
IMPC: |
Tlcd1 gene page |
|
Mutant Cell Lines: |
EPD0400_5_B11, EPD0400_5_C12, EPD0400_5_D10, EPD0400_5_E10, EPD0400_5_F10, EPD0400_5_F12 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 1045 starting at position 78070130 and ending at position 78071175 of Chromosome 11 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|